Cargando…
Paroxysmal Sympathetic Hyperactivity: It is Time to Use the New Diagnostic Criteria
How to cite this article: Krupanandan R. Paroxysmal Sympathetic Hyperactivity: It is Time to Use the New Diagnostic Criteria. Indian J Crit Care Med 2022;26(11):1165–1166.
Autor principal: | Krupanandan, Ravikumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983648/ https://www.ncbi.nlm.nih.gov/pubmed/36873596 http://dx.doi.org/10.5005/jp-journals-10071-24359 |
Ejemplares similares
-
Paroxysmal sympathetic hyperactivity in hemispheric intraparenchymal hemorrhage
por: Gao, Billy, et al.
Publicado: (2014) -
Paroxysmal sympathetic hyperactivity in neurological critical care
por: Verma, Rajesh, et al.
Publicado: (2015) -
Dexmedetomidine attenuates acute paroxysmal sympathetic hyperactivity
por: Peng, Yuan, et al.
Publicado: (2017) -
Paroxysmal Sympathetic Hyperactivity: An Old but Unrecognized Condition
por: Monteiro, Filipa Brás, et al.
Publicado: (2017) -
Effectiveness of Pharmacological Agents and Validation of Diagnostic Scales for the Management of Paroxysmal Sympathetic Hyperactivity in Hispanics
por: Abdelhakiem, Alaa K., et al.
Publicado: (2020)